Key result
Serotonergic antidepressants are associated with an elevated risk of hospitalisation and mortality in patients with COPD.
Why the study?
Are serotonergic antidepressants associated with increased hospitalisation and mortality in patients with COPD?
Are serotonergic antidepressants associated with increased hospitalisation and mortality in patients with COPD?
Highlights the potential risks of serotonergic antidepressants in COPD patients and advocates for collaborative, patient-centered care for depression.
Antidepressants are associated with elevated risk of hospitalisation and mortality. This underscores that the importance of having a collaborative care and patient-centred approach to manage depression in patients with COPD is worthy of consideration.http://ow.ly/BNkT30kGMqq
No takes yet. Share an insight, caveat, or question.
Abebaw Mengistu Yohannes (2018) studied this question. Serotonergic antidepressants are associated with an elevated risk of hospitalisation and mortality in patients with COPD.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: